Baxter completes first commercial batches of A/H1N1 vaccine
Baxter International Inc. announced that it completed production of its first commercial batches of CELVAPAN A/H1N1 pandemic vaccine in late July and is discussing plans for distribution with national health authorities, subject to obtaining appropriate authorizations.
A/H1N1 flu vaccine is formally put into production by China's domestic pharmaceuticalcompany Sinovac Biotech Ltd., also known as Beijing Kexing Bioproducts, Sep.3, 2009.